Our People

Anita Nador is a partner in INQ Law. She is a lawyer and registered patent agent in Canada and the United States, and a registered trademark agent in Canada. Prior to joining INQ Law, Anita was the founding global co-lead of the WIPR global ranked Trade Secret Group of a leading international law firm.  She was also on the executive of their life sciences group.  Anita services a range of clients - from startups and academic institutions to some of the world's largest pharmaceutical companies.

 

Recognized as a leader in her field by the world's top legal and IP rankings organizations, including IAM Strategy 300: The World's Leading IP Strategists, Anita focuses her practice on intellectual property (IP), regulatory and commercialization planning, primarily in the life sciences and chemical sectors. She was also the recipient of a 2016 Client Choice Award.

 

In addition to drafting, prosecuting and managing global IP portfolios, Anita is particularly distinguished for her ability to pair her technological expertise and sophisticated IP experience with her experience in corporate, transactional, and regulatory law –to assist clients' in realizing their commercial interests. Her practice encompasses all aspects of these areas, including negotiating and drafting various agreements and serving as an advisor and acting in-house counsel roles for institutional, corporate and investment entities and sitting on client internal committees such as MRC and PRC, developing SOPs and best practices and in-house training. Anita also assists clients with related agreements, such as asset purchase, license, development, manufacturing & supply, clinical trial, consulting, and master services agreements and has advised and conducted due diligence on many commercial transactions and financings.

 

A former researcher at Brigham and Women's Hospital/Harvard Medical School in Boston and Allelix Biopharmaceuticals in Mississauga, Anita grounds her advice in first-hand knowledge of the day-to-day commercial and scientific realities that shape her clients' businesses and objectives. To quote her clients, she is described as a “trustworthy and extremely knowledgeable adviser” and is routinely praised for her “outstanding” and “business – oriented and practical” advise.

Anita regularly speaks, teaches and writes on topics related to intellectual property, regulatory compliance and technology transfer issues and was an adjunct professor at the University of Toronto's Institute of Health Policy, Management and Evaluation for many years. Outside of law, Anita is very passionate about promoting and mentoring youth in underserviced communities through education and sport.

​

Recent Experience

• Acted for ITM Isotope Technologies Munich SE ("ITM"), a leading radiopharmaceutical biotech company, in their joint venture with Canadian Nuclear Laboratories ("CNL"), which manages and operates the national laboratory at Chalk River, Ontario on behalf of Atomic Energy of Canada Limited ("AECL"), for the industrial scale production of Actinium-225 (225Ac). See https://www.cnl.ca/itm-and-cnl-announce-the-launch-of-actineer-a-new-joint-venture-in-the-global-production-of-actinium-225/

• Acted for Genomadix Inc. in LuminUltra’s Acquisition and License of certain technologies. See https://www.businesswire.com/news/home/20240909727336/en/LuminUltra-Acquires-Legionella-Testing-Business-from-Genomadix-and-Inks-Strategic-License-to-Commercialize-Additional-Tests-for-Ultra-portable-Molecular-Diagnostic-Platform

• Acted for leading Canadian pharmaceutical company on various global vaccine manufacturing, supply, development and licensing transactions.

• Acting for various global pharmaceutical companies on regulatory compliance and commercialization strategies in Canada.

• Acting for ProtogenicTherapeutics Inc.(https://protagenic.com/) and Microbix Biosystems Inc. (www.microbix.com) in drafting, prosecuting and managing global IP portfolios.

 

Insights & Recognitions

• "Impact Deal of the Year" at the LMG Life Sciences 2024 Americas Awards for work in the CNL and AECL joint venture with IT, where ITM and CNL announced the launch of their joint venture in the global production of a rare medical isotope.

• IAM Strategy 300 Global Leaders 2025

• Best Lawyers in Canada 2025

• IAM Strategy 300: The World's Leading IP Strategists - 2024 Edition

• IAM Patent 1000 2024

• Lexpert Special Edition: Technology and Health Sciences 2024

• Managing Intellectual Property IP Stars 2024

• Canadian Legal Lexpert Directory 2024

• Who's Who Legal: Canada 2024

• Client Choice Award, 2016

 

Affiliations

Professional Licensing Organizations:

• Law Society of Ontario

• College of Patent Agents and Trademark Agents (CPATA)

 

Other:

• American Bar Association (ABA)

• American intellectual Property Law Association (AIPLA)

• AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle) – Commercialization of IP, Pharma and Trade Secrets Committees.

• BioteCanada – Market Access Working Group and Health Advisory Board Committees.

• Canadian Bar Association (CBA)

• Intellectual Property Institute of Canada (IPIC)

• Licensing Executives Society (LES)

 

Community Involvement

• Co-Chair and Board Member of Urban Squash Toronto (www.urbansquashtoronto.org)

• Mentor and Squash Coach, Urban Squash Toronto

• Former Board Member of the Toronto Consort (www.torontoconsort.org)